Fraud in Biomedical Research: Hearings Before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, First Session, March 31, April 1, 1981U.S. Government Printing Office, 1981 - 380 lappuses |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
action activities agency allegations amended anorexia nervosa application appropriate audit biomedical research Boston University budget CAPRON Chairman chapter clinical investigation Commissioner Committee concern conducted in compliance CONGRESS THE LIBRARY debarment Director disqualification ECOG ethical falsification FEDERAL REGISTER FELIG financial assistance Food and Drug fraud GORE Government grant-supported project grantee institution guidelines HANDLER hearing Hodgkin's disease human subjects indirect costs individual institutional review board insulin involved issue journals laboratory LAMONT-HAVERS LIBRARY OF CONGRESS LISOOK ment National Cancer Institute notify Office peer review period PHS grant principal investigator prior approval problem procedures proposed protocol question RAUB recombinant DNA research records regarding regulations request requirements responsibility scientific community scientists Secretary SHAMANSKY Soman specific sponsor statement Straus studies subcommittee submitted Subpart suspension terminated test article tion violations VOLKMER WALKER
Populāri fragmenti
278. lappuse - The head of each department is authorized to prescribe regulations, not inconsistent with law, for the government of his department, the conduct of its officers and clerks, the distribution and performance of its business, and the custody, use, and preservation of the records, papers, and property appertaining to it.
25. lappuse - American Academy of Arts and Sciences. American Association for the Advancement of Science. American College of Cardiology, Fellow.
235. lappuse - No person in the United States shall, on the basis of sex, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any education program or activity receiving Federal financial assistance.
129. lappuse - Policy. (a) Safeguarding the rights and welfare of subjects at risk in activities supported under grants and contracts from DHEW is primarily the responsibility of the institution which receives or is accountable to DHEW for the funds awarded for the support of the activity.
336. lappuse - Provided, however, That in the case of containers too small or otherwise unable to accommodate a label with sufficient space to bear all such information...
336. lappuse - In each of the three copies of the notice) of all informational material, including label and labeling, which is to be supplied to each Investigator: This shall Include an accurate description of the prior Investigations and experience and their results pertinent to the safety and possible usefulness of the drug under the conditions of the Investigation. It shall not represent that the safety or usefulness of the drug has been established for the purposes to be investigated. It shall describe all...
336. lappuse - Initiate clinical investigations with the drug: Such information should include identification of the person who conducted each investigation ; identification and qualifications of the individuals who evaluated the results and concluded that it is reasonably safe to initiate clinical investigations...
239. lappuse - Act, 1966," section 638, which specified that "none of the funds provided herein shall be used to pay any recipient of a grant for the conduct of a research project an amount equal to as much as the entire cost of such project," and any similar later enactments.
271. lappuse - No part of the funds appropriated under this Act shall be used to provide a loan, guarantee of a loan, a grant, the salary of or any remuneration whatever to any individual applying for admission, attending, employed by, teaching at, or doing research at an institution of higher education who has engaged in conduct on or after August 1, 1969, which involves the use of (or the assistance to others in the use of) force or the threat of force or the seizure of property under the control of an institution...
336. lappuse - Administration with a full report of the reason for discontinuing the investigation. The Food and Drug Administration will be prepared to confer with the sponsor on the need to discontinue the Investigation.